Gliclazide
- Generic Name
- Gliclazide
- Brand Names
- Diamicron
- Drug Type
- Small Molecule
- Chemical Formula
- C15H21N3O3S
- CAS Number
- 21187-98-4
- Unique Ingredient Identifier
- G4PX8C4HKV
- Background
Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It has been classified differently according to its drug properties in which based on its chemical structure, gliclazide is considered a first-generation sulfonylurea due to the structural presence of a sulfonamide group able to release a ...
- Indication
For the treatment of NIDDM in conjunction with diet and exercise.
- Associated Conditions
- Type 2 Diabetes Mellitus
- Associated Therapies
- -
Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.
- Conditions
- Interventions
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Yan Bi
- Target Recruit Count
- 106
- Registration Number
- NCT06222476
- Locations
- 🇨🇳
Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, Nanjing, Jiangsu, China
Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial
- Conditions
- Interventions
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2023-10-17
- Target Recruit Count
- 60
- Registration Number
- NCT06085703
- Locations
- 🇨🇳
Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, Nanjing, Jiangsu, China
Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers
- Conditions
- Interventions
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2021-08-18
- Lead Sponsor
- University of Sarajevo
- Target Recruit Count
- 15
- Registration Number
- NCT04198948
- Locations
- 🇧🇦
General Hospital Prim. Dr. Abdulah Nakas, Sarajevo, Bosnia and Herzegovina
Study of Sulphonylurea Synergy With Incretins
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 20
- Registration Number
- NCT03705195
- Locations
- 🇬🇧
Ninewells Hospital and Medical School, Dundee, United Kingdom
Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy Participants
- Conditions
- Interventions
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2019-07-16
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 40
- Registration Number
- NCT03467945
- Locations
- 🇩🇪
Please Contact the Merck KGaA Communication Center, Darmstadt, Germany
Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM Patients
- First Posted Date
- 2017-10-18
- Last Posted Date
- 2018-08-27
- Lead Sponsor
- Sherief Abd-Elsalam
- Target Recruit Count
- 60
- Registration Number
- NCT03313661
- Locations
- 🇪🇬
Sherief Abd-Elsalam, Cairo, Egypt
Antidiabetic Effects on Intrahepatic Fat
- Conditions
- Interventions
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2017-03-01
- Target Recruit Count
- 87
- Registration Number
- NCT03068065
- Locations
- 🇨🇳
at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, Nanjing, Jiangsu, China
HbA1c Variability in Type II Diabetes
- Conditions
- Interventions
- First Posted Date
- 2016-08-25
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- Weill Cornell Medical College in Qatar
- Target Recruit Count
- 150
- Registration Number
- NCT02879409
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers
- First Posted Date
- 2016-05-19
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Bial - Portela C S.A.
- Target Recruit Count
- 20
- Registration Number
- NCT02777671
- Locations
- 🇵🇹
Human Pharmacology Unit, S. Mamede do Coronado, Portugal
Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
- Conditions
- Interventions
- First Posted Date
- 2016-02-29
- Last Posted Date
- 2020-01-30
- Lead Sponsor
- University of Leicester
- Target Recruit Count
- 25
- Registration Number
- NCT02694263
- Locations
- 🇬🇧
University Hospitals of Leicester NHS Trust, Leicester, Leicestershire, United Kingdom
🇬🇧University Hospitals Birmingham NHS Foundation Trust, Birmingham, West Midlands, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.